A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors
Clinical trial NCT06001580 · COMPLETED
Trial details
- NCT number
- NCT06001580
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2023-10-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.